Geneos Wealth Management’s Ambev ABEV Stock Holding History

Geneos Wealth Management’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,182	Closed	-$17.3K	–	2463
2025 Q2	$17.3K	Buy	7,182 +1,980	+38%	+$4.82K	﹤0.01%	2097
2025 Q1	$12.1K	Buy	5,202 +1,736	+50%	+$3.47K	﹤0.01%	2181
2024 Q4	$6.41K	Sell	3,466 -500	-13%	-$1.11K	﹤0.01%	2230
2024 Q3	$9.68K	Buy	+3,966	New	+$8.89K	﹤0.01%	1854
2018 Q4	–	Sell	-750	Closed	-$3K	–	2377
2018 Q3	$3K	Hold	750	–	–	﹤0.01%	2151
2018 Q2	$3K	Hold	750	–	–	﹤0.01%	2017
2018 Q1	$5K	Hold	750	–	–	﹤0.01%	1833
2017 Q4	$4K	Hold	750	–	–	﹤0.01%	1851
2017 Q3	$4K	Hold	750	–	–	﹤0.01%	1793
2017 Q2	$4K	Hold	750	–	–	﹤0.01%	1760
2017 Q1	$4K	Hold	750	–	–	﹤0.01%	1712
2016 Q4	$3K	Hold	750	–	–	﹤0.01%	1731
2016 Q3	$4K	Hold	750	–	–	﹤0.01%	1609
2016 Q2	$4K	Hold	750	–	–	﹤0.01%	1545
2016 Q1	$3K	Buy	+750	New	+$3.45K	﹤0.01%	1583

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geneos Wealth Management's ABEV Position: Q3 2025 in Review

Geneos Wealth Management sold out of Ambev (ABEV) in Q3 2025, closing a stake of 7,182 shares — an estimated $17.3K sold.

Geneos Wealth Management first reported a position in ABEV in Q1 2016 and held it in 15 quarters. The position peaked at $17.3K in Q2 2025. 358 funds tracked by Wall St. Rank hold ABEV as of Q3 2025.

Geneos Wealth Management reported no remaining Ambev position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 7,182 Ambev shares in Q3 2025, an estimated $17.3K.
Geneos Wealth Management first reported a position in Ambev in Q1 2016 and held it in 15 quarters.
Geneos Wealth Management's Ambev position peaked at $17.3K in Q2 2025.
358 funds tracked by Wall St. Rank held Ambev as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.